Form NPORT-P GUGGENHEIM STRATEGIC For: Feb 27
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lyntris said to price IPO in lower half of range
- Guggenheim Reiterates Buy Rating on EyePoint Inc. (EYPT)
- Zentalis Pharmaceuticals launches public stock offering
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
